Global Intra-uterine Contraceptive Device Market to Become Worth US$ 00.00bn by 2024
Global Intra-Uterine Contraceptive Devices Market is projected to reach 4.9 billion by 2024, from USD billion in 2016 growing at a CAGR of 3.5% during the forecast period of 2017 to 2024, - Data Bridge Market Research new Insight’s.
Available a Free Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-intra-uterine-contraceptive-devices-market-2
The market is segmented– Industry Trends and Forecast to 2024
• By Product Type
o Hormonal IUCD,
o Copper IUCD
• By End-User
o Hospitals,
o Gynecology Clinics,
o Community Healthcare
• By Geography
o North America,
o Europe,
o APAC,
o South America,
o RoW
The actual calculation year for the report is 2016, while the historic data is for 2015 and the forecast period is still 2024.
Recent Developments:
Intrauterine contraceptive devices are most commonly known as IUDs/IUCDs.
These devices are inserted into the uterus by doctors and other healthcare professionals for contraception, by either immobilizing the sperms on their way to the fallopian tubes or by changing the uterine lining, so that the fertilized egg cannot be implanted in it.
The market for IUD devices is expected to be driven by factors such as increased incidence of unplanned pregnancy, rising number of initiatives by private firms and nonprofit organizations such as USAID, DKT International and Profamilia among others.
Also the Affordable Care Act (ACA) has opened up the fastest growing market for IUCD devices globally.
After the ACA was accredited the women in U.S. became more aware of IUD devices owing to private firms, who initiated the campaigns as the government was completely reimbursing the cost for IUCD devices.
Also with the advent of hormonal IUD products and other technological developments, the number of IUD products sold globally showed a gradual rise in the last decade.
Segmentation:
The Global Intra Uterine Contraceptive Devices market is segmented on the basis of product type, end-user and geography.
On the basis of product type the intra uterine contraceptive devices market is segmented into Hormonal IUCD and Copper IUCD.
Based on End-User the market is segmented into Hospitals, Gynecology Clinics, and Community Healthcare.
Geographic Segmentation:
Based on geography the Global Intra Uterine Contraceptive Devices Market is segmented into 5 geographical regions which are
• North America,
• Europe,
• Asia-Pacific,
• South America and
• Rest of the world
The report of this market shares countries such as
U.S. Canada,
Mexico,
Germany,
France,
U.K.,
Belgium,
Switzerland,
Belgium,
Turkey,
Japan,
China,
Singapore,
Brazil,
India,
Russia,
South Africa
Company Share Analysis:
The Global Intra-Uterine Contraceptive Devices Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.
The report includes market shares of intra-uterine devices market for
• Global,
• Europe,
• North America,
• Asia Pacific and
• Rest of the World
Major Players:
Some of the other players in this market include-
• DKT International,
• Egemen International,
• Melbea AG,
• Ocon Medical Ltd.,
• Pregna International Limited,
• Medical Engineering Corporation SA and,
• SMB Corporation, and
• Meril Life Sciences Pvt. Ltd.,
• Medu Scientific Ltd,
• China RH Contraceptives Co., Ltd,
• Sanghai Jolly Medical Education Co., Ltd,
• Bernstein Leibhard LLP,
• Zheijang Daji Medical Instruments, Ltd.,
• Nimble International,
• AME Line,
• Technico,
• Cepeo,
• Contraceptivos,
• Injeflex Ind And Com Ltda,
• Bersil,
• Amed
• And among others…
Other Market Insights:
Global Molecular Spectroscopy Market, latest insights by Data Bridge Market Research states that the market is growing at CAGR of 5.0% in the forecast period 2017 to 2024, expected to reach USD 6.712 Billion by 2024.
MORE INSIGHTS
Global Vital Signs Monitoring Market, latest insights by Data Bridge Market Research states that the market is growing at CAGR of 6.5% in the forecast period 2017 to 2024, expected to reach USD 62.02.2 million by 2024.
Improve knowledge About Research Report @ https://databridgemarketresearch.com/news/product-launch/global-intra-uterine-contraceptive-devices-market-2/
About Us-
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Us-
Data Bridge Market Research
US: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Website: https://databridgemarketresearch.com
Available a Free Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-intra-uterine-contraceptive-devices-market-2
The market is segmented– Industry Trends and Forecast to 2024
• By Product Type
o Hormonal IUCD,
o Copper IUCD
• By End-User
o Hospitals,
o Gynecology Clinics,
o Community Healthcare
• By Geography
o North America,
o Europe,
o APAC,
o South America,
o RoW
The actual calculation year for the report is 2016, while the historic data is for 2015 and the forecast period is still 2024.
Recent Developments:
Intrauterine contraceptive devices are most commonly known as IUDs/IUCDs.
These devices are inserted into the uterus by doctors and other healthcare professionals for contraception, by either immobilizing the sperms on their way to the fallopian tubes or by changing the uterine lining, so that the fertilized egg cannot be implanted in it.
The market for IUD devices is expected to be driven by factors such as increased incidence of unplanned pregnancy, rising number of initiatives by private firms and nonprofit organizations such as USAID, DKT International and Profamilia among others.
Also the Affordable Care Act (ACA) has opened up the fastest growing market for IUCD devices globally.
After the ACA was accredited the women in U.S. became more aware of IUD devices owing to private firms, who initiated the campaigns as the government was completely reimbursing the cost for IUCD devices.
Also with the advent of hormonal IUD products and other technological developments, the number of IUD products sold globally showed a gradual rise in the last decade.
Segmentation:
The Global Intra Uterine Contraceptive Devices market is segmented on the basis of product type, end-user and geography.
On the basis of product type the intra uterine contraceptive devices market is segmented into Hormonal IUCD and Copper IUCD.
Based on End-User the market is segmented into Hospitals, Gynecology Clinics, and Community Healthcare.
Geographic Segmentation:
Based on geography the Global Intra Uterine Contraceptive Devices Market is segmented into 5 geographical regions which are
• North America,
• Europe,
• Asia-Pacific,
• South America and
• Rest of the world
The report of this market shares countries such as
U.S. Canada,
Mexico,
Germany,
France,
U.K.,
Belgium,
Switzerland,
Belgium,
Turkey,
Japan,
China,
Singapore,
Brazil,
India,
Russia,
South Africa
Company Share Analysis:
The Global Intra-Uterine Contraceptive Devices Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.
The report includes market shares of intra-uterine devices market for
• Global,
• Europe,
• North America,
• Asia Pacific and
• Rest of the World
Major Players:
Some of the other players in this market include-
• DKT International,
• Egemen International,
• Melbea AG,
• Ocon Medical Ltd.,
• Pregna International Limited,
• Medical Engineering Corporation SA and,
• SMB Corporation, and
• Meril Life Sciences Pvt. Ltd.,
• Medu Scientific Ltd,
• China RH Contraceptives Co., Ltd,
• Sanghai Jolly Medical Education Co., Ltd,
• Bernstein Leibhard LLP,
• Zheijang Daji Medical Instruments, Ltd.,
• Nimble International,
• AME Line,
• Technico,
• Cepeo,
• Contraceptivos,
• Injeflex Ind And Com Ltda,
• Bersil,
• Amed
• And among others…
Other Market Insights:
Global Molecular Spectroscopy Market, latest insights by Data Bridge Market Research states that the market is growing at CAGR of 5.0% in the forecast period 2017 to 2024, expected to reach USD 6.712 Billion by 2024.
MORE INSIGHTS
Global Vital Signs Monitoring Market, latest insights by Data Bridge Market Research states that the market is growing at CAGR of 6.5% in the forecast period 2017 to 2024, expected to reach USD 62.02.2 million by 2024.
Improve knowledge About Research Report @ https://databridgemarketresearch.com/news/product-launch/global-intra-uterine-contraceptive-devices-market-2/
About Us-
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Us-
Data Bridge Market Research
US: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Website: https://databridgemarketresearch.com